AAPE Hair Ampoule

Manufacturer
PROSTEMICS Co., Ltd. | Prostemics Co., Ltd. Factory
Effective date
2021-05-28
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:40:36

Label at a glance#

ProductAAPE Hair Ampoule
Active ingredientPanthenol
Label structure9 sections

Indications and uses

■ Improves effects of hair elasticity.

Dosage and administration

Gently mix with AAPE powder to dissolve the mixture. Take proper amount and gently apply onto the scalp

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Panthenol 0.5%

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

[Powder] MANNITOL, Human Adipose Derived Mesenchymal Cell Exosomes.

[Solvent] Water, Alcohol, Propylene Glycol, Glycerin, Lactic Acid, Hydroxyacetophenone, Propanediol, Polyquaternium-7, Niacinamide, Polysorbate 20, Butylene Glycol, Caprylhydroxamic Acid, Disodium EDTA, Glycyrrhiza Glabra (Licorice) Root Extract, Camellia Sinensis Leaf Extract, Panax Ginseng Root Extract, Sophora Angustifolia Root Extract, Angelica Gigas Root Extract, Cnidium Officinale Root Extract, Glycine Max (Soybean) Seed Extract, Polygonum Multiflorum Root Extract, 1,2-Hexanediol, Sodium Benzoate

PURPOSE

OTC - PURPOSE SECTION

Hair elasticity

WARNINGS

WARNINGS SECTION

For external use only
1. Discontinue use if signs of irritation or rashes appear. If symptoms get worse, consult with a dermatologist. 1) In case of swelling, itching, or other side effects while or after using this product
2. Do not apply to open wounds.
3. Avoid contact with eyes.
Storage and handling
4. Keep in the refrigerator at 2-6°C.
5. Keep out of reach of children.
6. Avoid direct sunlight.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN

Uses

INDICATIONS & USAGE SECTION

■ Improves effects of hair elasticity.

Directions

DOSAGE & ADMINISTRATION SECTION

Gently mix with AAPE powder to dissolve the mixture.
Take proper amount and gently apply onto the scalp

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
62041-330-022024-01-30C16284748780-11030e364-fbe9-111a-e063-dadaa90a10e2aaad2ce0-12c3-447d-8867-2213f90340c1

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
62041-330-01AAPE Hair Ampoule6 mL in 1 CONTAINERLIQUID61
62041-330-02AAPE Hair Ampoule6 in 1 CARTONLIQUID61

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
62041-330AAPE HAIR AMPOULE (PANTHENOL) LIQUID [PROSTEMICS CO., LTD.]1Legacy NDC, 2 package rows20210529_aaad2ce0-12c3-447d-8867-2213f90340c1.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
62041-33062041-330-01, 62041-330-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
PanthenolWV9CM0O67ZACTIB
Water059QF0KO0RIACT
Alcohol3K9958V90MIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
62e59cca-7436-4101-b5ed-3e8ec73f0c3caaad2ce0-12c3-447d-8867-2213f90340c12021-05-28WarningsExact identifier
spl id: 62e59cca-7436-4101-b5ed-3e8ec73f0c3c
spl set id: aaad2ce0-12c3-447d-8867-2213f90340c1

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.